Logo 3.jpg
Raptor Power Systems has selected Edge Data Solutions, Inc. as its Exclusive Immersion Partner for Crypto Mining
July 21, 2021 08:00 ET | Edge Data Solutions, Inc.
ATLANTA, GA, July 21, 2021 (GLOBE NEWSWIRE) -- Edge Data Solutions, Inc. (OTC:EDGS) (“EDSI” or the “Company”) a leading edge data center and cloud infrastructure company, announces an agreement with...
Logo 3.jpg
Edge Data Solutions, Inc. Partners with LightSpeed Hosting, LLC to Become Exclusive Immersion Partner for Medina Datacenter
October 30, 2020 09:30 ET | Edge Data Solutions, Inc.
ATLANTA, Oct. 30, 2020 (GLOBE NEWSWIRE) -- October 30, 2020– Edge Data Solutions, Inc. (OTC:EDGS) (“EDSI” or the “Company”) a leading-edge datacenter and cloud infrastructure company announces that...
Logo 3.jpg
Edge Data Solutions, Inc. Launches up to $3 Million Capital Raise as a General Solicitation Offering Under Regulation D 506(c) of the Securities Act
October 13, 2020 09:31 ET | Edge Data Solutions, Inc.
ATLANTA, Oct. 13, 2020 (GLOBE NEWSWIRE) -- Edge Data Solutions, Inc. (OTC:EDGS) (“EDSI” or the “Company”) a leading edge datacenter and cloud infrastructure company announced today the details of...
Full Latin without Latin logo.png
Innovative drug launched for rare, isolating, “light intolerance” disorder
April 16, 2020 02:53 ET | Clinuvel Pharmaceuticals Limited
MELBOURNE, Australia and MENLO PARK, Calif., April 16, 2020 (GLOBE NEWSWIRE) -- Americans living with a rare genetic disorder that forces them to choose between self-isolation in the dark, or...
Full Latin without Latin logo.png
FDA to Review Australian Drug for Genetic Disorder of Absolute Light Intolerance
June 25, 2018 06:00 ET | Clinuvel Pharmaceuticals Limited
MELBOURNE, Australia, June 25, 2018 (GLOBE NEWSWIRE) -- In a landmark case, the US Food and Drug Administration (FDA) has begun a review of an innovative drug developed for patients who carry a rare...
US FDA pathway opens to SCENESSE® following Fast Track designation for treatment of EPP
July 06, 2016 08:00 ET | Clinuvel Pharmaceuticals Limited
FDA awards Fast Track Designation¹ to expedite review of SCENESSE® in EPPNDA filing allowed on a rolling basisFDA hosting a Scientific Workshop² on EPP to learn more about disease and drug treatment ...
NSS Labs Tests Reveal That Nearly 90% of Consumers Are Inadequately Protected Against Phishing Attacks by End Point Protection Solutions
January 30, 2013 10:00 ET | NSS Labs
AUSTIN, TEXAS--(Marketwire - Jan 30, 2013) - NSS Labs today released the latest Comparative Analysis Report™ from its 2013 Group Test for Consumer End Point Protection (EPP), which evaluated...
Chemetall's Gardobond(R) EPP Process Wins the Battle Against Higher Energy Prices
June 24, 2011 11:07 ET | Chemetall NJ
NEW PROVIDENCE, N.J., June 24, 2011 (GLOBE NEWSWIRE) -- Chemetall, an innovator in surface treatment, drastically reduces customers' energy costs with their Gardobond® EPP Process. EPP or...